Related Experiment Video
Updated: Jul 29, 2025

Intraoperative Gastroscopy for Tumor Localization in Laparoscopic Surgery for Gastric Adenocarcinoma
Published on: August 9, 2016
Neoadjuvant and adjuvant approaches in gastroesophageal cancers
Magdalena K Scheck1, Michael Masetti, Sylvie Lorenzen
1III. Medizinische Klinik and Poliklinik, TUM School of Medicine, Technical University of Munich, Munich, Germany.
Purpose Of Review:
Despite advances in the perioperative treatment of locally advanced (T2-4 and/or N+) gastroesophageal cancer with evolving chemoradiotherapy and chemotherapy regimens, prognosis remains poor. Biomarker-based approaches with targeted therapies and immune checkpoint inhibition present a new opportunity to improve response rate and overall survival. This review aims to shed light on the current treatment strategies and therapy options that are under investigation for the curatively intended perioperative treatment of gastroesophageal cancer.
Recent Findings:
A major step for patients with advanced esophageal cancer and insufficient response to chemoradiotherapy was the implementation of immune checkpoint inhibition in the adjuvant treatment with positive effects on survival duration and quality of life (CheckMate577). Various studies that seek to further integrate immunotherapy or targeted therapy into (neo-) adjuvant treatment are on their way and show promising results.
Summary:
Ongoing clinical research tries to increase the effectivity of standard of care approaches for the perioperative treatment of gastroesophageal cancer. Biomarker based immunotherapy and targeted therapy bear the opportunity to further improve the outcome.
Insights
Advances in perioperative treatment for gastroesophageal cancer are improving outcomes. Biomarker-based targeted therapies and immune checkpoint inhibitors offer new hope for better survival rates.
Area of Science:
- Oncology
- Gastroenterology
- Immunotherapy
Background:
- Prognosis for locally advanced gastroesophageal cancer remains poor despite current perioperative treatments.
- Evolving chemoradiotherapy and chemotherapy regimens have shown limited success in improving outcomes.
Approach:
- This review examines current and investigational perioperative treatment strategies for curatively intended gastroesophageal cancer.
- Focus is placed on biomarker-based approaches, including targeted therapies and immune checkpoint inhibition.
Key Points:
- Immune checkpoint inhibition has demonstrated positive effects on survival in advanced esophageal cancer post-chemoradiotherapy (e.g., CheckMate577).
- Ongoing studies are integrating immunotherapy and targeted therapy into neoadjuvant and adjuvant settings.
- Biomarker-driven strategies hold significant promise for enhancing treatment efficacy.
Conclusions:
- Despite progress, there is a continued need to improve response rates and overall survival in gastroesophageal cancer.
- Future research directions involve optimizing standard care with novel immunotherapeutic and targeted agents.
- Personalized medicine approaches utilizing biomarkers are crucial for advancing gastroesophageal cancer treatment.
More Related Videos
03:32Single Incision Plus One Port Laparoscopic Proximal Gastrectomy with Double Channel Anastomosis for Gastric Cancer Treatment
Published on: December 27, 2024
10:42Subculture and Cryopreservation of Esophageal Adenocarcinoma Organoids: Pros and Cons for Single Cell Digestion
Published on: July 6, 2022
Related Concept Videos
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...